Sort
85,873 grants matching “alzheimers”
Structure-based discovery of allosteric ligands for G Protein Coupled Receptors
$1,239,663Brian K Kobilka · Stanford University · U19 · FY2016 · GM
Structure-based discovery of allosteric ligands for G Protein Coupled Receptors
$1,239,663Brian K Kobilka · Stanford University · U19 · FY2017 · GM
Clinical Core
$1,239,509Hillel Grossman · Icahn School Of Medicine At Mount Sinai · P30 · FY2021 · AG
Development of DYRK1A allosteric modulator for the treatment of Alzheimer's Disease
$1,239,325Gian Luca Araldi · Avanti Biosciences, Inc. · SB1 · FY2023 · AG
Early Events in Alzheimer Pathogenesis
$1,238,846Sue T Griffin · Univ Of Arkansas For Med Scis · P01 · FY2010 · AG
Life-course social adversity, pesticide exposure, and cognitive outcomes among an ongoing cohort of mid-life Latina women in an under served agricultural region
$1,238,686Jacqueline Marie Torres · University Of California, San Francisco · R01 · FY2020 · AG
Novel platform for research brain banking and characterization using integrated traditional and quantitative analyses to promote precision neuropathology of Alzheimer's disease
$1,238,307Christopher D Keene · Allen Institute · U19 · FY2022 · AG
THE PET RADIOTRACER TRANSLATION AND RESOURCE CENTER (PET-RTRC)
$1,237,294Robert J Gropler · Washington University · P41 · FY2019 · EB
NPTX2: Preserving memory circuits in normative aging and Alzheimer's Disease
$1,237,047Carol A. Barnes · University Of Arizona · R01 · FY2021 · AG
Early Events in Alzheimer Pathogenesis
$1,236,791Sue T Griffin · Univ Of Arkansas For Med Scis · P01 · FY2009 · AG
Core A - Admin Core
$1,236,654Mary Sano · Icahn School Of Medicine At Mount Sinai · P30 · FY2025 · AG
Tau Protein Aggregation Inhibitors for Tauopathies
$1,236,507Qubai Hu · Proteotech, Inc. · R44 · FY2014 · AG
GESTALT-Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing
$1,236,157Luigi Ferrucci · National Institute On Aging · ZIA · FY2019 · AG
Small molecule targeting an epigenetic regulator for the treatment of osteoarthritis
$1,235,850Maddalena Adorno · Dorian Therapeutics, Inc. · U44 · FY2024 · AG
Biological And Biochemical Characterization Of Sigma Receptors
$1,235,844Tsung-Ping Ping Su · National Institute On Drug Abuse · Z01 · FY2008 · DA
PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research
$1,235,390Catherine M. Tangen · Fred Hutchinson Cancer Research Center · U01 · FY2019 · CA
Systems Genetics Analysis of Sex Differences in Alzheimer's Disease
$1,235,110Catherine Cook Kaczorowski · Jackson Laboratory · R01 · FY2022 · AG
A non-pharmacological multi-modal therapy to improve sleep and cognition and reduce mild cognitive impairment risk
$1,234,826Daniel Gartenberg · Proactive Life, Inc. · R44 · FY2021 · AG
INTRAVENOUS IMMUNOGLOBULIN (IVIg) FOR TREATMENT OF AD (IVIg)
$1,234,665Norman R. Relkin · University Of California, San Diego · U01 · FY2007 · AG
Core 1: Administrative Core
$1,234,640Maria Mori Brooks · University Of Pittsburgh At Pittsburgh · U19 · FY2022 · AG
ALZHEIMER'S DISEASE CORE CENTER
$1,234,436William R Markesbery · University Of Kentucky · P30 · FY2006 · AG
Center for Mesoscale Mapping
$1,234,408Bruce R Rosen · Massachusetts General Hospital · P41 · FY2021 · EB
Anatomic, Physiologic, and Cognitive Pathology of AD
$1,234,191Rush University Medical Center · P01 · FY2002 · AG
Discovery of Novel Drugs for Alzheimer's Disease
$1,234,178James W. Simpkins · University Of North Texas Hlth Sci Ctr · P01 · FY2006 · AG
Vanderbilt Alzheimer's Disease Research Center
$1,233,944Angela L. Jefferson · Vanderbilt University Medical Center · P20 · FY2020 · AG